Secondly, the effect of acute elevation of plasma GLP‐1 concentrations for a few hours in a limited number of patients do not necessarily reflect the chronic elevation of GLP‐1 receptor agonist levels in a larger population with type 2 diabetes treated with a long‐acting GLP‐1 receptor agonist. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.